Ananda Impact Ventures Research
Investment Thesis
Ananda Impact Ventures is a Munich-based impact venture firm founded in 2009 by Florian Erber and Johannes Weber after a roadtrip across Germany looking for early-stage companies tackling serious social problems. Its current pitch is "the home for systems disruptors": it backs founders building frontier technology to reshape entire systems, arguing that outsized returns and outsized impact are inextricably linked when the problem is hard enough. The firm says it invests before the world is ready, is explicitly anti-consensus, and wants cross-domain founders who speak science, business and impact.
Scale-Based Focus Areas
The website organizes the thesis by scale: planetary (space data for protecting Earth, e.g. OroraTech, AIRMO), global environmental systems (Jua, Ocean Ledger), field and infrastructure (Decade, EcoG, Resourcify, Pulsetrain), human (AI-driven healthcare such as IESO, Pheiron, Ovom, Closed Loop Medicine), microscopic (NatureMetrics, Mycolever, Klim) and molecular (Differential Bio, Quantistry, Nordic Salt Cycle). Portfolio sector labels include AI-Driven Healthcare, Blue Economy, Decarbonising Industry, FemTech, Future of Work, NatureTech, EdTech, Biosecurity and Energy Transition. Fund V is stated to target European challenges from biodiversity and ageing to planetary health and biosecurity.
Stage Focus
Early stage: pre-seed, seed and Series A. The firm says it leads rounds with conviction and follows on over the life of the company.
Check Size
Average initial investment is EUR 0.5M to 3.0M, with up to EUR 8M invested over the lifetime of a company. Press coverage of the Fund V close describes EUR 0.5M to 10M tickets.
Lead Tendency
The website says it leads rounds. Recent public examples include co-leading the EUR 4.8M seed round in hexafarms alongside GGF, so the firm both leads and co-leads.
Recent Activity
In January 2026 Ananda announced a EUR 73M first close of its fifth Core Impact Fund, its largest first close ever and well above the EUR 50M target, backed by the European Investment Fund among others. As of the portfolio page the firm was looking to make its first investment from Fund V, and Fund IV investments (2024 to 2025) include Nordic Salt Cycle, Pulsetrain, Pheiron, Jua, Ocean Ledger, Differential Bio, Mycolever, Entelo Bio, Elio, Decade, Ovom and Quantistry. The firm manages about EUR 270M across five funds and cites 49 investments since 2010 and 4,000+ jobs created.
Portfolio Highlights
Fund III and IV companies include OroraTech (wildfire detection from space), NatureMetrics (biodiversity data), IESO Digital Health (digital mental healthcare), Klim (regenerative agriculture), DrDoctor, EcoG, Caspar Health and Resistomap. Fund I closed at 2x MOIC in 2022 and was closer to venture philanthropy; Fund II and III broadened to scalable social businesses and then spacetech and climate. The portfolio page lists additional Fund I to III companies only as logos, which were not captioned and are not captured here.
Team
- Johannes Weber: General Partner and Founder
- Florian Erber: General Partner and Founder
- Bernd Klosterkemper: Partner
- Zoe Peden: Partner
- Victor Szabo: Principal
- Mike Kennedy: Venture Partner
- Chloe Lambert: Analyst
- Venture Partners and advisors: Martina Samwer, Sandeep Jain, Hedda Pahlson-Moller, Dr. Steffen Zoller, Diana Meyel, Dr. Thomas Jetter, Dr. Christian Saller
Decision Process
Partnership model with two founding General Partners and several partners. The team is built around biologists, engineers, chemists and entrepreneurs and tells founders they can skip the problem slide, so technical depth in diligence is expected.
Founder Preferences
Cross-domain thinkers who bridge technical innovation with commercial strategy and impact, scientific founders building through complexity, and companies that transform systems from within. The firm also runs a Founders' Health Programme.
Geographic Focus
European by design with global ambition, with a pan-European remit and a German base in Munich.